TABLE 2.
Summary table of variance of the main treatments and interactions.
| Treatment | Y | DM | NC | NRA |
GSLs |
||||||||||||||
| Act | Tot | AcSt | 4HGB | 4MGB | GBC | DMB | GER | GNPF | GRA | GSV | DGTB | PRO | GAL | GNT | Tot | ||||
| Species (S) | ns | *** | ns | *** | ** | ns | *** | ** | *** | ** | * | ** | *** | ns | ns | * | ns | ns | ** |
| Nitrogen level (N) | * | ** | ** | * | * | ns | ns | ns | * | ns | ns | ns | ns | ns | ns | ns | * | ns | ns |
| Light (L) | ns | ns | *** | ** | ** | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns |
| FS vs. LED | ns | ns | ns | ** | ** | ns | * | * | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns |
| R + B vs. R,B | * | ns | * | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns | * | ns | ns | ns | ns |
| R vs. B | ns | * | *** | ** | ** | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns |
| S × N | ns | * | ns | ** | ** | ns | ns | ns | * | ns | ns | ** | ** | ** | ns | * | ns | ns | * |
| S × L | ns | ns | ns | *** | *** | ns | ns | ns | ns | *** | ns | ns | ns | * | ns | ns | ns | ns | * |
| S × (FS vs. LED) | ns | ns | ns | ** | ** | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns |
| S × (R + B vs. R,B) | ns | ns | ns | ns | ns | ns | ns | ns | ** | *** | ns | ns | ns | ** | ns | ns | ns | ns | ** |
| S × (R vs. B) | ns | * | ns | *** | *** | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns |
| N × L | ns | ns | * | *** | ** | ns | ns | ns | ns | * | ns | ns | ns | ns | ns | ns | ns | ns | ns |
| N × (FS vs. LED) | ns | ns | ns | ** | * | ns | ns | ns | ns | ** | ns | ns | ns | ns | ns | ns | ns | ns | ns |
| N × (R + B vs. R,B) | ns | ns | * | ns | ns | ns | ns | ns | ns | * | ns | ns | ns | ns | ns | ns | ns | ns | ns |
| N × (R vs. B) | ns | ns | ** | *** | *** | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns |
| S × N × L | ns | ns | ns | *** | *** | ns | ns | ns | ns | ns | ns | ns | ns | * | ns | ns | ns | ns | ns |
| S × N × (FS vs. LED) | ns | ns | ns | ** | ** | ns | ns | ns | ns | * | ns | ns | ns | ns | ns | ns | ns | ns | ns |
| S × N × (R + B vs. R,B) | ns | * | ns | ns | ns | ns | ns | ns | * | ns | ns | ns | ns | * | ns | ns | ns | ns | ns |
| S × N × (R vs. B) | ns | ns | * | *** | *** | ns | ns | ns | ns | ns | ** | ns | ns | ns | ns | ns | ns | ns | ns |
Significance of F: ns, not significant for P ≤ 0.05; *, **, and *** = significant for P ≤ 0.05, 0.01 and 0.001. Y, yield; DM, dry Matter; NC, nitrate concentration; NRA, nitrate reductase activity; Act, nitrate reductase activity actual; Tot, nitrate reductase activity total; AcSt, nitrate reductase activity activation state; GSLs, glucosinolates; 4HGB, 4-hydroxyglucobrassicin; 4MGB, 4-methoxyglucobrassicin; GBC, glucobrassicin; DMB, dimeric-glucosativin; GER, glucoerucin; GNPF, gluconapoleiferin; GRA, glucoraphanin; GSV, glucosativin; DGTB, diglucothiobeinin; PRO, progoitrin; GAL, glucoalyssin; GNT, gluconasturtiin; GSLs Tot, total of glucosinolates). B, BLUE, peak at 460 nm; R, RED, peak at 660 nm; R + B, RED + BLUE, 75% red + 25% blue.